CDC flags 8.5% XDR Shigella rate, raising stool-testing risk for UAE emergency clinics

Extensively drug-resistant Shigella, a diarrhoeal infection that can spread through sexual contact, rose from 0% of tested US isolates during 2011-2015 to 8.5% in 2023, a warning for UAE emergency clinics that treat acute diarrhoea after travel or sexual exposure.

The highest-stakes readers are COOs, medical directors and CFOs. COOs need triage and reporting workflows. Medical directors need stool culture and susceptibility testing before antibiotics in severe cases. CFOs need clean coding, network checks and documented medical necessity when patients are covered by Daman, Thiqa, Sukoon or another UAE insurer.

What the overseas signal says

The news story, carried by WBAL from Gulf Coast News and Weather, points to shigellosis caused by Shigella, a bacterium that spreads through faecal-oral contact, contaminated food or water, and sexual contact involving anal exposure. Symptoms can include diarrhoea, fever, stomach cramps and bloody stool.

The underlying Centers for Disease Control and Prevention MMWR, published on 9 April 2026, analysed 16,788 Shigella isolates with resistance data from 2011 to 2023. It identified 510 XDR isolates, with 86.2% of patients male among cases with age and sex data. About 37.6% of patients with hospitalisation data were admitted.

“The percentage of XDR isolates increased from 0% during 2011-2015 to 8.5% in 2023.” — CDC MMWR, 9 April 2026

The CDC defines XDR Shigella as resistant to ampicillin, azithromycin, ceftriaxone, ciprofloxacin and trimethoprim-sulfamethoxazole. That matters because these medicines sit close to normal outpatient and emergency prescribing for bacterial diarrhoea, STI-linked proctocolitis and travel-associated gastroenteritis.

Why Dubai providers should care first

Dubai emergency departments, urgent-care centres and gastroenterology clinics see residents, tourists and workers who may present first with “food poisoning” instead of an STI concern. Dubai Health Authority (DHA) regulates Dubai health facilities, and DHA’s Sheryan circular archive includes a public circular titled Enhancing Surveillance of Drug Resistance Shigella, addressed to health professionals and facilities under DHA jurisdiction.

The immediate action is clinical. A patient with severe diarrhoea, blood in stool, fever, dehydration, recent travel, HIV, immunosuppression, antimicrobial exposure, or sexual exposure involving anal contact needs a stool test pathway that can support culture and susceptibility testing. The CDC says many people recover in 5 to 7 days without antibiotics, but severe illness or high-transmission settings may require treatment guided by susceptibility data.

• Add sexual exposure and travel prompts to acute diarrhoea history taking in emergency and urgent care.
• Confirm whether positive molecular tests trigger reflex culture for susceptibility testing.
• Advise patients to avoid sex for at least 2 weeks after diarrhoea ends, based on CDC prevention guidance.
• Check insurer network status, laboratory benefit rules and preauthorisation triggers before non-emergency send-out testing.

There is no UAE-wide public cash tariff for Shigella stool culture or susceptibility testing. Operators should obtain the facility’s lab code, payer code and contracted tariff from the hospital laboratory information system or insurer portal before quoting a patient. For walk-in patients, the safer commercial script is: “price depends on your plan network, sample type and whether susceptibility testing is required.”

Abu Dhabi and northern emirates need the same workflow

Department of Health Abu Dhabi (DOH) oversees Abu Dhabi and Al Ain facilities. A DOH communicable disease circular published in 2026 states that suspected or confirmed cases covered by the circular must be reported through the DOH e-notification system within 1 calendar day. It also states that patients with known Shigella infection should avoid food handling and child or patient care until clearance criteria are met.

For Sharjah, Ajman, Umm Al Quwain, Ras Al Khaimah and Fujairah, Ministry of Health and Prevention (MOHAP) is the relevant federal regulator for private-sector licensing and public-health oversight. The UAE government portal says doctors, pharmacists, pharmacy technicians and medical professionals in government and private sectors must report communicable disease cases within 24 hours.

The insurance question is narrower. Emergency dehydration, sepsis concern or bloody diarrhoea is more likely to be handled as urgent care. Routine screening after exposure may sit under outpatient benefits, exclusions or network-specific lab rules. Patients with Daman or Thiqa coverage in Abu Dhabi, or Sukoon and other DHA-permitted plans in Dubai, should verify the approved emergency provider and laboratory network before non-urgent testing.

The practical close is simple. UAE clinics should treat XDR Shigella as a triage, laboratory and reporting problem before it becomes a local outbreak problem. Patients with severe diarrhoea, blood in stool, dehydration, fever, recent travel, HIV, immunosuppression or relevant sexual exposure should seek licensed emergency care. Operators and patients can use the UAE Open Healthcare Directory to find licensed emergency care providers, then confirm coverage through the insurer’s provider locator.